Разработана вакцина против covid-19


International application PCT/RU2018/050004, priority 20.01.2017

Patent applications for inventions:

  • Евразийская №2017000003, заявлена 20.01.2017 г., решение о выдаче патента от 25.06.2019
  • США 16/478,038, дата подачи 15.07.2019 г.,
  • Тайланда 1901004386, дата подачи 18.07.2019,
  • Австралии 2018210739, дата подачи 19.08.2019 г.,
  • Европы 18742237.3, дата подачи 20.08.2019 г.

The invention makes it possible to increase muscle mass, recovery after sports training, as well asregeneration of nervous tissue and normalization of blood supply to the brain with a significantreduction in the dose of the substance used and the frequency of its use. In addition, it has a nootropiceffect, and can also be used for the prevention andtherapy of cardiac extrasystoles.

Assessment of the significance of this development